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ABSTRACT: 42 
Objective: To elucidate the genetic cause of a large five generation South Indian 43 
family with multiple individuals with predomiantly an upper limb postural tremor and 44 
posturing in keeping with another form of tremor, namely, dystonic tremor (DT).  45 
Methods: Whole genome SNP microarray analysis was undertaken to look for copy 46 
number variants (CNVs) in the affected individuals.. 47 
Results: Whole genome SNP microarray studies identified a tandem duplicated 48 
genomic segment of chromosome 15q24 present in all affected family members. 49 
Whole genome sequencing demonstrated that it comprised a ~550kb tandem 50 
duplication encompassing the entire LINGO1 gene.  51 
Conclusions: The identification of a genomic duplication as the likely molecular cause 52 
of this condition, resulting in an additional LINGO1 gene copy in affected cases, adds 53 
further support for a causal role of this gene in tremor disorders, and  implicates 54 
increased expression levels of LINGO1 as a potential pathogenic mechanism. 55 
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Tremor is a common movement disorder and in recent years it has become clear that essential 59 
tremor (ET) may be a group of diseases or a syndrome with clinical features that overlap with 60 
dystonia and dystonic tremor (DT) 1. Both may be associated with isolated upper limb postural 61 
and kinetic tremor, although DT has different characteristics and is often associated with 62 
posturing or other evidence of dystonia 2, 3. However, the considerable overlap in symptoms 63 
and signs has led to misdiagnosis of each with the other 4. This phenotypic heterogeneity is a 64 
complicating factor when interpreting the results of genetic studies of familial tremor. The lack 65 
of ET- or DT-specific serum, or imaging biomarkers or defining neuropathological features, 66 
mean that clinical assessment is required to distinguish between the two. 67 
The LINGO1 gene (leucine-rich repeat and Ig domain containing Nogo receptor interacting 68 
protein-1) is selectively expressed in the central nervous system 5-7. Previous studies have 69 
identified LINGO1 as a notable genetic risk factor displaying significant association between 70 
intragenic SNP rs9652490 and familial ET, and the same LINGO1 SNP was replicated in 71 
independent case control studies of ET as well as Parkinson’s disease 8-13. In the current 72 
study, we report our investigation of a large family from Southern India with multiple individuals 73 
presenting with an early onset, bilateral, postural tremor of the upper limbs with some 74 
associated dystonic features, suggestive of DT, associated with a tandem duplication of the 75 
chromosome 15 genomic region encompassing the entire LINGO1 gene. 76 
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MATERIALS & METHODS 78 
Clinical studies  79 
The investigated family is from Kerala, a Southern state of India, with a total of 11 affected 80 
individuals from five generations (figure 1A) recruited with informed written consent including 81 
permission to publish photographs. Six participants with a history of tremor (figure 1A: III:5; 82 
III:9; II:9; IV:1; IV:2 and V:1) underwent a general medical and neurological examination by 83 
the regional consultant neurologist, and a structured videotaped neurological examination as 84 
well as Archimedes spirals were assessed by senior neurologists specializing in movement 85 
disorders (table 1). The videotaped neurological examination included assessments of gait, 86 
tremor at rest, dystonia, postural tremor of the arms, and with each hand the finger-nose 87 
manoeuvre, the drawing of a spiral,  and pouring of water. The other 5 individuals with tremor 88 
(II:1; II:6; II:10; III:16 and IV:8) had their affected status confirmed with an examination 89 
conducted by the local consultant neurologist. Four other family members (II:4, II:11, III:11 and 90 
IV:5) were examined by the same consultant neurologist and confirmed to have no evidence 91 
of tremor or dystonia.  92 
 93 
Microarray analysis and flourescent in situ hybridisation (FISH) 94 
Venous blood was collected in EDTA and PAXgene Blood RNA tubes (PreAnalytiX), and skin 95 
biopsy performed in three cases (III:5, IV:2 and II:9) for FISH studies. Genomic DNA and RNA 96 
samples were extracted from peripheral blood following standard protocols. Genome-wide 97 
SNP genotyping was undertaken using Illumina HumanCytoSNP-12 v2.1 SNP microarrays, 98 
and image data processed using Illumina GenomeStudio software to generate genotype calls, 99 
B allele frequency and logR ratio values. These were further analysed for CNVs using 100 
Illumina’s KaryoStudio software. To minimise false positive CNV calls, filtering approaches 101 
were applied to exclude smaller repeats (<100 kb) and common CNVs from Database of 102 
Genomic Variants (http://dgv.tcag.ca/dgv/app/home). For FISH analysis, BlueFISH probe 103 
RP11-114H24 was used to confirm chromosomal duplication in individuals II:9; III:5 and IV:2. 104 
 105 
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Genomic library preparation 106 
Genomic DNA (~3 μg) was fragmented by sonication using a Bioruptor (UCD-200; Diagenode, 107 
Seraing, Liege, Belgium) to an average size of ~400 bp, and DNA purified using 1.2 volumes 108 
Ampure XP (Agencourt). End repair and dA tailing were carried out using NEBNext modules 109 
(New England Biolabs, Hitchin, Hertfordshire, UK), with DNA purification using 1.8 volumes 110 
Ampure after each step. DNA fragments were then ligated to paired-end adapters for Illumina 111 
sequencing using Epicentre Fast-Link DNA ligation kit (Cambio, Dry Drayton, Cambridgeshire 112 
UK). The entire ligation reaction was separated on a 1.2% agarose gel and DNA fragments in 113 
the size range ~400-450 bp excised. DNA was extracted from the gel slice using the QIAquick 114 
gel extraction kit (Qiagen, Manchester, UK) and analysed on a high-sensitivity chip for the 115 
Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA). Adapter-ligated DNA (50 116 
ng) was amplified for 6 cycles using Herculase II Fusion DNA Polymerase (Agilent 117 
Technologies) and Illumina PE_PCR primers 1 and 2, then diluted for sequencing. Sequencing 118 
was carried out by the Exeter Sequencing Service (School of Biosciences, University of 119 
Exeter, Exeter, UK) on an Illumina HiSeq2500 using 100 bp paired-end reads in rapid run 120 
mode, yielding a total of 23.8 Gb of sequence. Reads were aligned to the human reference 121 
genome (build GRCh37/hg19) using BWA, and duplicate reads removed using Picard, yielding 122 
an average coverage depth of ~7.5X reads per base. 123 
 124 
 125 
Standard protocol approvals, registrations, and patient consents.  126 
The study was approved and performed under the ethical guidelines issued by our institutions 127 
for clinical studies, with written informed consent obtained from all participants for genetic 128 
studies. 129 
  130 
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RESULTS  131 
Clinical studies 132 
The extended pedigree of the family is presented in figure 1A, and clinical details of the tremor 133 
and salient neurological features are presented in table 1, including age of onset. The clinical 134 
examination was supplemented by review of videotaped neurological examinations of 135 
individuals III:5; III:9; IV:1; IV:2 and V:1 by two neurologists with specialization in movement 136 
disorders (EL, TTW). The presence of sustained postures of the hands/wrists in 4 of 5 affected 137 
individuals, as well as a yes-yes head tremor in one additional individual with abnormal hand 138 
postures, are atypical for ET and confirmed the diagnosis of DT. Two exemplar videos of 139 
individuals III:5 and II:9 demonstrate the dystonic posturing (video 1). On examination of II:1; 140 
II:6; II:9; II:10; III:16 and IV:8 mild bilateral postural hand limb tremor, with variable degree of 141 
thumb or index finger posturing was detected. II:4, II:11, III:11 and IV:5 displayed no tremor  142 
or posturing.  Five of the six affected individuals had postural tremor in association with 143 
dystonic posturing and only one had  isolated postural tremor (table 1). Although 144 
electromyography can be useful in differentiating ET from dystonic tremor, the obvious 145 
posturing in the upper limb in all cases obviating the need for this additional test. None of the 146 
affected individuals had other abnormal salient neurology, including evidence of parkinsonism 147 
or abnormal eye movements. 148 
  149 
Genetic studies 150 
Genome-wide SNP microarray analysis (Illumina Human CytoSNP-12v2.1) of all available 151 
family members identified a single notable genomic rearrangement in affected family 152 
members, a duplication of chromosome 15q24.3-q25.1 in all nine affected family members 153 
(figure 1A-B, figure e-1A). This duplicated region, delimited by KaryoStudio, was found to 154 
contain 14 RefSeq genes (figure 1B; table e-1) and was confirmed in affected family members 155 
using FISH analysis (using BlueFish probe RP11-114H24; chr15:78146252-78322027, figure 156 
1C). Targeted next generation sequencing of an affected patient (III:16) was then used in order 157 
to precisely map the chromosomal breakpoints of the duplication. This identified read pairs 158 
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mapping ~550kb apart in reverse-forward rather than forward-reverse orientation, indicative 159 
of a tandem duplication event (figure 1B; figure e-1A,). The exact coordinates of the 160 
rearrangement event (chr15:77775483-78331797dup [hg19]) were identified in reads 161 
spanning each breakpoint (figure e-1B), located in genes HMG20A and TBC1D2B 162 
respectively. The read count across the region indicates an average coverage increase from 163 
approximately 7.5x to 10x, broadly consistent with an expected ~50% increase in the number 164 
of reads for a heterozygous duplication. The 14 genes located within the duplicated region 165 
(figure 1B) were investigated for candidacy, which identified only a single stand-out candidate 166 
with a role in brain development or function; LINGO1. 167 
PCR primers were positioned in order to produce an amplicon specific to the genetic sequence 168 
created at the boundary between the tandem duplications, generating a product of 1184 base 169 
pairs arising from this de novo event. Dideoxy sequencing of this PCR product confirmed the 170 
location of the duplication event to chr15:77775487-78331797 [hg19]. This facilitated the 171 
genotyping of family members using a simple PCR-based strategy to identify family members 172 
who have inherited the rearragnement. PCR analysis on all individuals from the pedigree 173 
confirmed co-segregation of the rearrangement in affected family members (figure 1A), as well 174 
as its absence from 100 age matching healthy controls from the same geographical region.  175 
  176 
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DISCUSSION 177 
Here we investigated an extended Indian family with multiple individuals affected by a 178 
movement disorder involving tremor. The presence of abnormal upper limb postures in all 11 179 
affected individuals along with the presence of only mild tremor is most consistent with DT 180 
rather than ET in this family 1.  181 
 182 
As noted above, previous genome-wide association studies have demonstrated association 183 
between DNA sequence variants in the LINGO1 gene and ET. With the case we report now, 184 
the potential involvement of a duplication involving the LINGO1 gene may suggest a similar 185 
genetic and molecular mechanistic basis to some cases of ET and DT. LINGO1 protein is 186 
known to interact with Nogo-66 receptor (NgR1) and p75 neurotrophin receptor (p75NTR) or 187 
TROY, to form an NgR1 complex which binds to inhibitory molecules such as Nogo-A 14, 15. 188 
The NgR1 complex Nogo-A activates RhoA as a negative regulator for neuronal survival, 189 
axonal regeneration, oligodendrocyte maturation and neuronal myelination 15-21. Notably the 190 
p75NTR – sortilin (SORT1) receptor complex has previously been implicated in tremor 191 
phenotypes via a p.Gly171Ala SORT1 missense variant, which impaired expression of both 192 
protein members of the sortilin-p75NTR complex 22. As such LINGO1 represents a strong 193 
candidate gene for involvment in movement disorders such as DT and ET, and consistent with 194 
this previous genome-wide association studies have indeed indicated an association between 195 
variants in LINGO1 and ET 9-13. However, all identified risk variants are located in LINGO1 196 
intronic regions, and subsequent sequencing of LINGO1 coding exons in ET patients have 197 
failed to identify putative pathogenic sequence variants 9-11, 23, 24.  198 
The studies reported here define a previously undescribed duplication event encompassing 199 
the LINGO1 gene present in multiple individuals of this extended Indian family. While it is not 200 
possible to exclude involvement of other genes in the duplicated region, LINGO1 represents 201 
the only stand-out functional candidate in the region. This finding lends us to speculate that 202 
increased transcription and ensuing gene activity deriving from the additional (trisomic) copy 203 
of LINGO1 are the likely pathogenic cause of this condition. This indicates that the previously 204 
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identified intronic LINGO1 gene variants displaying association with ET may result in the 205 
condition by directly influencing (or being in linkage disequlibrium with variants that directly 206 
influence) native gene transcription. Consistent with this notion, a previous study detected 207 
increased levels of LINGO1 in the cerebellum ET patients 25. Thus while the outcome of 208 
duplication of the other genes located within the genomic region defined in our study requires 209 
further exploration our data, combined with existing studies of LINGO1 in ET, indicate that 210 
hypermorphic mutation leading to increased transcriptional or protein activity of LINGO1 211 
represents a likely pathogenic cause. This may manifest itself via an increased density of 212 
basket cell processes generated by an increased LINGO1 dosage effect, leading to an 213 
inhibitory effect on Purkinje cell GABAergic neurones. Decreased or inhibited cerebellar 214 
inhibitory output has been demonstrated to cause postural, kinetic tremor as well as motor 215 
incoordination in GABAA α1 knockout mice 24. In the olivary animal models of action tremor, 216 
it has also been shown that such action tremor is a primarily electrophysiological entity caused 217 
by abnormal olivary-cerebellar excitatory output 26. Thus it is tempting to speculate that this 218 
may result from an imbalance of excitatory-inhibitory inter-neuronal connection secondary to 219 
the dosage effect of LINGO1, and it would be of interest to observe the effect of LINGO1 220 
protein agonists on the olivary animal models of ET to investigate this hypothesis. The data 221 
from this study are consistent with this notion and demonstrate LINGO1 copy number gain in 222 
familial postural tremor suggestive of a LINGO1 dosage disease mechanism.  223 
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 234 
Table 1. Clinical features of affected individuals in the family in figure 1A  235 
Individual 
(sex/age, y) 
Age of onset 
of tremor 
Site of 
onset 
Upper limb dystonia/posturing Tremor Additional features 
III:5 (M/46) 16 Both arms Right thumb hyper-extension 
Left fingers flexion 
Mild bilateral postural arms and 
tremulous Archimedes spiral 
‘Yes-yes’ head tremor 
None 
III:9 (M/63) 54 Both arms Mild bilateral hyper-extension of 
thumbs, posturing of right wrist 
Fine bilateral postural upper limb tremor None 
II:9 (M/80) unknown unknown Posturing of wrist and fingers, 
predominantly on left 
Rest tremor 
Irregular distal upper limb postural 
tremor and left sided action tremor 
Tremulous Archimedes spiral 
Painful shoulder leading to 
reduced range of movements 
and apparent proximal 
weakness 
IV:1 (F/15) 13 Both arms None Mild bilateral postural asymmetric upper 
limb tremor 
None 
IV:2 (M/22) 16 Both arms Mild bilateral thumb extension 
and assymetric finger flexion 
Mild bilateral postural upper limb tremor None 
V:1 (F/16) 6 Right arm Mild posturing right fingers Asymmetric postural right upper limb 
tremor 
None 
236 
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Figure Legends 237 
 238 
Figure 1. Pedigree and genomic analysis of the Indian family. A: Pedigree of large 239 
multigenerational Indian family exhibiting genotype of the affected and unaffected individuals 240 
studied using whole genome SNP microarray analysis and FISH (‘+’ identified the presence 241 
of duplication, ‘-‘ identifies wild type allele). B: Chromosome 15q24.3-q25.1 duplicated region 242 
highlighted with red circle encompassing LINGO1 gene. C: FISH confirming presence of the 243 
duplication on chromosome 15 in affected individuals showing enhanced signal for the 244 
derivative chromosome (circled to right of figure).  245 
  246 
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